BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 28576247)

  • 1. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
    Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Lin A; Patel N; Yoo D; DeMartelaere S; Bouchard C
    J Burn Care Res; 2011; 32(5):547-60. PubMed ID: 21799437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with toxic epidermal necrolysis treated in a burn center.
    Yarbrough DR
    J Burn Care Rehabil; 1996; 17(1):30-3. PubMed ID: 8808356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson Syndrome: A Challenging Diagnosis.
    Davis WD; Schafer PA
    Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?
    Abood GJ; Nickoloff BJ; Gamelli RL
    J Burn Care Res; 2008; 29(1):269-76. PubMed ID: 18182932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-threatening Skin Disorders Treated in the Burn Center: Impact of Health care-associated Infections on Length of Stay, Survival, and Hospital Charges.
    Hermiz SJ; Diegidio P; Ortiz-Pujols S; Garimella R; Weber DJ; van Duin D; Hultman CS
    Clin Plast Surg; 2017 Jul; 44(3):597-602. PubMed ID: 28576248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burn unit care of Stevens Johnson syndrome/toxic epidermal necrolysis: A survey.
    Le HG; Saeed H; Mantagos IS; Mitchell CM; Goverman J; Chodosh J
    Burns; 2016 Jun; 42(4):830-5. PubMed ID: 26810444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of toxic epidermal necrolysis in a 15-year-old girl.
    Clennett S; Hosking G
    J Wound Care; 2003 Apr; 12(4):151-4. PubMed ID: 12715488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at Burn Centers and Nonburn Centers.
    Nygaard RM; Endorf FW
    J Burn Care Res; 2020 Sep; 41(5):945-950. PubMed ID: 32498082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong.
    Ying S; Ho W; Chan HH
    Burns; 2001 Jun; 27(4):372-5. PubMed ID: 11348746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations.
    Hockett KC
    Clin J Oncol Nurs; 2004 Feb; 8(1):27-30, 55. PubMed ID: 14983759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to the management of toxic epidermal necrolysis in a burn centre.
    Green D; Law E; Still JM
    Burns; 1993 Oct; 19(5):411-4. PubMed ID: 8216769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
    Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients Treated With a Medicine-Led Multidisciplinary Approach.
    Lewcun JA; Vagonis A; Kontzias C; Newsom M; Drake M; Feldman MJ
    J Burn Care Res; 2024 Jan; 45(1):165-168. PubMed ID: 37698266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.